Enantiomers of selected fused heterocyclics and uses thereof
US7498333B2 · kind B2 · utility
0Cited by
3References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 18, 2005 |
| Grant date | Mar 3, 2009 |
| Priority date | — |
| Expiry date | Dec 2, 2025 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D513/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to novel compounds having the structural formula (I)and to their pharmaceutical compositions and to their methods of use. These novel compounds provide a treatment or prophylaxis of cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.